federal_register: 2020-05318

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2020-05318 Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry; Extension of Comment Period Notice The Food and Drug Administration (FDA or Agency) is extending the comment period for the notice entitled "Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry" that appeared in the Federal Register of October 25, 2019. The Agency is taking this action to allow interested persons additional time to submit comments. 2020-03-16 2020 3 https://www.federalregister.gov/documents/2020/03/16/2020-05318/drug-products-labeled-as-homeopathic-draft-guidance-for-food-and-drug-administration-staff-and https://www.govinfo.gov/content/pkg/FR-2020-03-16/pdf/2020-05318.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA or Agency) is extending the comment period for the notice entitled "Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry" that appeared in the Federal Register of...  

Links from other tables